Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06458075 · ClinicalTrials.gov registry record · NA
Intervention to Improve Communication and Medication Adherence in Lupus
A NA study of Systemic Lupus Erythematosus, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT06458075 is a NA study of Systemic Lupus Erythematosus that is actively recruiting participants, run by Duke University. The registered enrollment target is 480 participants, above the 376-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06458075, a NA study of Systemic Lupus Erythematosus, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
CO-LEAD is an intervention to improve patient-provider communication and medication adherence among patients with systemic lupus erythematosus (SLE). The purpose of this study is to optimize the culturally appropriate delivery and test the effect of the CO-LEAD intervention, which includes the following: 1. clinicians will be provided with a program to teach them to use effective communication strategies with patients to review real-time pharmacy refill date, engage and formulate solutions to adherence barriers, and collaboratively overcome adherence barriers. 2. use of a reliable and valid patient-reported measure of the extent of and reasons for nonadherence that helps patients identify and communicate their adherence barriers with clinicians proactively, efficiently, and comprehensively.
Conditions Studied
Interventions
- BEHAVIORAL CO-LEAD
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06458075
The ClinicalTrials.gov registry entry for NCT06458075 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 376-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (28% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 1 intervention - of which CO-LEAD is the first listed.
NCT06458075 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06458075 about?
NCT06458075 is a clinical study titled "Intervention to Improve Communication and Medication Adherence in Lupus". CO-LEAD is an intervention to improve patient-provider communication and medication adherence among patients with systemic lupus erythematosus (SLE). The purpose of this study is to optimize the culturally appropriate delivery and test the effect of the CO-LEAD intervention, which includes the foll...
What is the current status of trial NCT06458075?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2024-07-01. Estimated completion is 2028-12.
What conditions does trial NCT06458075 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus.
What interventions are being tested in trial NCT06458075?
The interventions under investigation include: CO-LEAD (BEHAVIORAL).
Who is sponsoring clinical trial NCT06458075?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06458075 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Peer Approaches to Lupus Self-management
ACTIVE NOT RECRUITING · NA
-
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
ACTIVE NOT RECRUITING · NA
-
REACH (Restore Energy, Activity Can Help) Lupus Study
ACTIVE NOT RECRUITING · NA
-
Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology
COMPLETED · NA
-
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.